Kidney Transplant Clinical Trials

Clinical trials related to Kidney Transplant Procedure

Multimodal Ultrasound Assessment of Kidneys From Donation After Brain Death (DBD) to Predict the Risk Model of Early Postoperative Renal Insufficiency in Renal Transplantation

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

The objective of this observational study is to investigate the multimodal ultrasound parameters of kidneys from brain-dead organ donors prior to donation, in order to construct a predictive model for assessing the risk of early transplant renal dysfunction after kidney transplantation in recipients. The primary question this study aims to address is: Can multimodal ultrasound data from brain-dead organ donor kidneys accurately predict early post-transplant renal dysfunction? Ultrasonography, as a routine examination before organ donation, will be utilized, and the study results will be concluded within one year after participation in this study.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Recipient Study Participants Age ≥18 years;

• Underwent allogeneic kidney transplantation at this hospital;

• Signed informed consent form.

• Donor Study Participants Brain-deceased organ donors;

• Completed organ donation at the First Affiliated Hospital of Shandong First Medical University (Qianfoshan Hospital of Shandong Province);

• Brain death criteria:

• Deep coma (with clear etiology and exclusion of reversible causes);

• Absence of brainstem reflexes;

• No spontaneous respiration;

• Confirmed by at least two confirmatory tests (SLSEP, EEG, TCD), with re-evaluation 12 hours after the initial determination.

• Standard Criteria Donor (SCD):

• Age 10-39 years;

⁃ Cause of death unrelated to cerebrovascular disease;

‣ Serum creatinine \<133 μmol/L;

∙ No history of hypertension.

• Expanded Criteria Donor (ECD):

• Age \>60 years; OR

• ② Age 50-59 years with two of the following three criteria:

• Cause of death related to cerebrovascular disease;

⁃ Serum creatinine \<133 μmol/L;

‣ History of hypertension.

• Signed informed consent form.

Locations
Other Locations
China
The First Affiliated Hospital of Shandong First Medical University
RECRUITING
Jinan
Contact Information
Primary
Bei Wang
wangbei1224@126.com
(86)+18853182401
Time Frame
Start Date: 2025-01-01
Estimated Completion Date: 2026-03-31
Participants
Target number of participants: 27
Related Therapeutic Areas
Sponsors
Leads: Bei Wang

This content was sourced from clinicaltrials.gov